DD143608A5 - Verfahren zur herstellung von 4'-substituierten 2,4-dichlor-alpha-(imidazol-n-ylmethyl)-dibenzylaethern - Google Patents

Verfahren zur herstellung von 4'-substituierten 2,4-dichlor-alpha-(imidazol-n-ylmethyl)-dibenzylaethern Download PDF

Info

Publication number
DD143608A5
DD143608A5 DD79212866A DD21286679A DD143608A5 DD 143608 A5 DD143608 A5 DD 143608A5 DD 79212866 A DD79212866 A DD 79212866A DD 21286679 A DD21286679 A DD 21286679A DD 143608 A5 DD143608 A5 DD 143608A5
Authority
DD
German Democratic Republic
Prior art keywords
imidazol
ylmethyl
substituted
dichloro
general formula
Prior art date
Application number
DD79212866A
Other languages
German (de)
English (en)
Inventor
Dante Nardi
Elena Massarani
Alberto Tajana
Mario Veronese
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of DD143608A5 publication Critical patent/DD143608A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DD79212866A 1978-05-18 1979-05-14 Verfahren zur herstellung von 4'-substituierten 2,4-dichlor-alpha-(imidazol-n-ylmethyl)-dibenzylaethern DD143608A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/78A IT1096361B (it) 1978-05-18 1978-05-18 Dibenzileteri sostituiti terapeuticamente attivi

Publications (1)

Publication Number Publication Date
DD143608A5 true DD143608A5 (de) 1980-09-03

Family

ID=11208025

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79212866A DD143608A5 (de) 1978-05-18 1979-05-14 Verfahren zur herstellung von 4'-substituierten 2,4-dichlor-alpha-(imidazol-n-ylmethyl)-dibenzylaethern

Country Status (29)

Country Link
JP (1) JPS605592B2 (xx)
AR (1) AR219596A1 (xx)
AT (1) AT372950B (xx)
AU (1) AU523053B2 (xx)
CA (1) CA1115718A (xx)
CH (1) CH639075A5 (xx)
DD (1) DD143608A5 (xx)
DE (1) DE2917244C2 (xx)
DK (1) DK153838C (xx)
EG (1) EG14345A (xx)
ES (1) ES480552A1 (xx)
FI (1) FI71309C (xx)
FR (1) FR2426047A1 (xx)
GB (1) GB2025395B (xx)
GR (1) GR68396B (xx)
HU (1) HU182565B (xx)
IE (1) IE48372B1 (xx)
IL (1) IL57245A (xx)
IT (1) IT1096361B (xx)
MX (1) MX5927E (xx)
NL (2) NL189255C (xx)
NO (1) NO152840C (xx)
NZ (1) NZ190412A (xx)
PH (1) PH14782A (xx)
PT (1) PT69537A (xx)
SE (1) SE444812B (xx)
SU (1) SU816399A3 (xx)
YU (1) YU112279A (xx)
ZA (1) ZA792015B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1155853A (en) * 1980-06-06 1983-10-25 Joseph A. Martin Imidazole derivatives and preparation thereof
EP0117811A3 (fr) * 1983-02-23 1987-06-03 Sanofi S.A. Compositions pharmaceutiques antifongiques utilisables par voie orale
FR2541114B1 (fr) * 1983-02-23 1986-04-11 Sanofi Sa Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
DE3413365A1 (de) * 1984-04-09 1985-12-19 Merz + Co GmbH & Co, 6000 Frankfurt Substituierte phenylethylderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
IT1200422B (it) * 1985-03-19 1989-01-18 Ripari Gero Ist Farm Biolog Composto con attivita' antimicrobia,sua preparazione e composizioni farmaceutiche che lo contengono
ES2249992B1 (es) 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
GB1475271A (en) * 1975-04-30 1977-06-01 Pfizer Ltd 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents

Also Published As

Publication number Publication date
GB2025395A (en) 1980-01-23
CA1115718A (en) 1982-01-05
JPS605592B2 (ja) 1985-02-12
IT7823546A0 (it) 1978-05-18
FR2426047B1 (xx) 1982-11-05
DE2917244C2 (de) 1985-09-05
SE7904319L (sv) 1979-11-19
NL930014I1 (nl) 1993-05-03
DE2917244A1 (de) 1979-11-22
NL930014I2 (nl) 1993-09-16
IT1096361B (it) 1985-08-26
GR68396B (xx) 1981-12-29
NL189255C (nl) 1993-02-16
IE48372B1 (en) 1984-12-26
IL57245A (en) 1983-02-23
NO791599L (no) 1979-11-20
SU816399A3 (ru) 1981-03-23
FI71309C (fi) 1986-12-19
PH14782A (en) 1981-12-09
DK196579A (da) 1979-11-19
GB2025395B (en) 1982-07-28
JPS54151974A (en) 1979-11-29
DK153838B (da) 1988-09-12
ZA792015B (en) 1980-04-30
SE444812B (sv) 1986-05-12
DK153838C (da) 1989-01-30
HU182565B (en) 1984-02-28
EG14345A (en) 1983-09-30
YU112279A (en) 1983-01-21
CH639075A5 (fr) 1983-10-31
FR2426047A1 (fr) 1979-12-14
MX5927E (es) 1984-08-29
NO152840C (no) 1985-11-27
NL7903872A (nl) 1979-11-20
IE790958L (en) 1979-11-18
FI791543A (fi) 1979-11-19
ES480552A1 (es) 1980-04-01
IL57245A0 (en) 1979-09-30
AU4714979A (en) 1979-11-22
NZ190412A (en) 1981-03-16
FI71309B (fi) 1986-09-09
AT372950B (de) 1983-11-25
AU523053B2 (en) 1982-07-08
PT69537A (fr) 1979-05-01
NO152840B (no) 1985-08-19
ATA345079A (de) 1983-04-15
AR219596A1 (es) 1980-08-29

Similar Documents

Publication Publication Date Title
AT407832B (de) Fungizides mittel, eine verbindung hierfür, verfahren zu ihrer herstellung und verfahren zu ihrer verwendung
DE1940388C3 (de) l-(ß-Aryl) äthylimidazolderivate, ihre Herstellung und diese enthaltende fungizide und bakterizide Mittel
DE2037610C3 (xx)
EP0041673B1 (de) Imidazolderivate, deren Herstellung sowie diese enthaltende Präparate
EP0011769B1 (de) Hydroxyethyl-azole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2041771B2 (de) derivate
EP0011768B1 (de) Hydroxypropyl-triazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH646693A5 (de) Benzylimidazol-derivate.
DE2839388A1 (de) Imidazolylvinylaether und deren verwendung
EP0003796B1 (de) Substituierte Diphenyl-imidazolyl-methane, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DD143608A5 (de) Verfahren zur herstellung von 4'-substituierten 2,4-dichlor-alpha-(imidazol-n-ylmethyl)-dibenzylaethern
DE2920437A1 (de) Geometrische isomere von 4,4- dimethyl-1-phenyl-2-(1,2,4-triazol-1-yl)- 1-penten-3-olen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2811916A1 (de) Antimikrobielle mittel
DE3010093A1 (de) 1,1-diphenyl-2-(1.2.4-triazol-1-yl)-aethan-1-ole, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
EP0088874A2 (de) Azolyl-phenoxy-tetrahydrofuran-2-yliden-methane, Verfahren zu ihrer Herstellung sowie antimikrobielle Mittel, die diese Stoffe enthalten
DE69500329T2 (de) Neue Triazol-Verbindung mit fungizider Wirkung, deren Herstellung und Verwendung
DE2242454A1 (de) 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0370300A2 (de) Cyclopropyl-Substituierte Azolylmethylcarbinole, Verfarhren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0022969B1 (de) Antimykotische Mittel, die Azolyl-alkenole enthalten und ihre Herstellung
EP0533056A2 (de) Substituierte Aminopropane, Verfahren zu ihrer Herstellung und ihre Verwendung als Antimykutiku
DE2059949B2 (de) Thienyl-fettsäurederivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0037049A1 (de) Biphenylyl-imidazolylethan-Derivate, Verfahren zu ihrer Herstellung und diese Verbindingungen enthaltende Arzneimittel
DE2851143A1 (de) Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0041615B1 (de) Verwendung von Imidazolyl-vinyl-ketonen und-carbinolen als antimikrobielle Mittel
EP0149814B1 (de) Azolylmethylcycloacetale, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel